期刊文献+

慢性充血性心力衰竭患者血清白三烯B_4变化的临床研究 被引量:1

A Clinical Study on the Change of Serum LTB_4 in Patients with Chronic Congestive Heart Failure
原文传递
导出
摘要 目的探讨充血性心力衰竭(CHF)患者血清白三烯B4(LTB4)水平与心功能的关系。方法对82例CHF患者按纽约心脏病学会心功能分级标准分为Ⅱ-Ⅳ级组,根据超声心动图检查结果,将入选者分为左心室正常组(左心室舒张末期容积≤55mm)和左心室增大组(左心室舒张末期容积≥55mm),用酶联免疫吸附法(ELISA法)检测血清LTB4含量,并与20例健康体检者进行对照。结果CHF组患者血清LTB4含量明显高于正常对照组(P<0.01),心功能Ⅲ、Ⅳ级的血清含量均高于Ⅱ级(P<0.01),左室增大组较左室正常组LTB4血清含量显著升高(P<0.01),LTB4的血清含量与CHF患者的严重程度及心脏左室增大均呈正相关(P<0.01)。结论LTB4是心功能受损的敏感指标,可以作为CHF相关的非创伤性指标之一。 Objective To explore the relationship between the change of serum LTB4 and cardiac functions in patients with chronic heart failure (CHF). Methods According to the cardiac functions as listed out in the NYHF standard, 82 patients were classified as Grade Ⅱ , Ⅲ and Ⅳ group. After echocardiography examination, the patients were then divided into normal left ventricular group (LVEDV ≤ 55 mm) and enlarged left ventricular group (LVEDV ≥ 55 mm). The results were compared with 20 healthy subjects in the control group. Serum LTB4 was determined by ELISA. Results The level of serura UFB4 was higher in the CHF group than the control group (P〈0.01). LTB4 was also higher in Grade Ⅲ and Ⅳ patients than the Grade II patients (P〈0.01). When compared with the enlarged left ventricular group, serum LTB4 was also increased significantly in the left ventrieular normal group (P〈0.01). The level of LTB4 was positively correlated with the degree of severity of the cardiac functions and enlargement of the left ventrium (P〈0.01). Conclusion Serum LTB4 can be used as a sensitive indicator of impaired cardiac functions. It can be used as a non-invasive indicator of CHF.
出处 《热带医学杂志》 CAS 2009年第5期550-552,共3页 Journal of Tropical Medicine
关键词 充血性心力衰竭 白三烯B4 左心室增大 congestive heart failure leukotriene B4 enlarged left ventricular
  • 相关文献

参考文献6

  • 1Keulenaer G, Brutsaert D. Pathogenesis of heart failure changing one optual paradigms [J]. Acta Cardiol, 1998,53: 131-141.
  • 2Peters-Golden M. Molecular mechanism of leukotriene synthesis: the changing paradigm [J]. Clin Exp Allergy, 1998,28 : 1059-1065.
  • 3Sampson SE, Costello JF, Sampson AP. The effect of inhaled leukotriene B4 in normal and in asthmatic subjects [J]. Am J Respir Crit Care Med, 1997, 155(5):1789-1792.
  • 4唐皓 ,MA Zhong-fu ,梁艳冰 ,翟诚顺 ,熊仕秋 ,熊艳 .多器官功能障碍综合征患者外周血白三烯B4与p38丝裂原活化蛋白激酶的变化[J].中国危重病急救医学,2005,17(4):231-233. 被引量:6
  • 5Brike FW, Meade C J, Anderskewitz R, et al. In vitro and in vivo pharmacological characterization of BILL 284, a novel and potent leukotriene B4 receptor antagonist [J ]. J Pharmacol Exp Ther, 2001,297 : 458-466.
  • 6慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2413

二级参考文献12

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1414
  • 2Bone R C.Immunological dissonance:a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome(MODS)[J].Ann Intern Med,1996,125:680-687.
  • 3Peters-Golden M.Molecular mechanism of leukotriene synthesis:the changing paradigm[J].Clin Exp Allergy,1998,28:1059-1065.
  • 4Brike F W,Meade C J,Anderskewitz R,et al.In vitro and in vivo pharmacological characterization of BILL 284,a novel and potent leukotriene B4 receptor antagonist[J].J Pharmacol Exp Ther,2001,297:458-466.
  • 5Sampson S E,Costello J F,Sampson A P.The effect of inhaled leukotriene B4 in normal and in asthmatic subjects[J].Am J Respir Crit Care Med,1997,155:1789-1792.
  • 6Ma X L,Kumas,Gao F,et al.Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and impresses cardiac function after myocardial ischemia and referfusion[J].Circulation,1999,99:1685-1691.
  • 7Rosengart M R,Arbabi S,Nathens A,et al.Mitogen-activated protein kinase(MAPK) in the ICU:potential prognostic factors[J].Shock,2000,13(Suppl 12):106-110.
  • 8Manthey C L,Wang S W,Kinney S D,et al.SB 202190,a selective inhibitor of p38 mitogen-activated protein kinase,is a powerful regulator fo LPS-inducefd mRNAs in monocytes[J].J Leuko Biol,1998,64:409-417.
  • 9Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
  • 10姚咏明,盛志勇.MODS抗炎治疗研究的反思[J].中国危重病急救医学,1999,11(8):456-458. 被引量:74

共引文献2417

同被引文献14

  • 1Thambo JB, Bordachar P, Garrigue S, et al.Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing[J]. Circulation, 2004,110 (25) : 3766-3772.
  • 2Dhingra R, Pencina MJ, Wang TJ, et al.Electroeardiographic QRS duration and the risk of congestive heart failure:the Framingham Heart Study [J]. Hypertension, 2006,47 (5) : 861-867.
  • 3Okin PM, Roman M J, Devereux RB, et al.Electrocardiographic identification of increased left ventricular mass by simple voltage- duration products [ J ]. J Am Coll C ardiol, 1995,25 (2) :417-423.
  • 4Duarte JD, Magalhaes LP, Santana OO, et al.Prevalence and prognostic value of ventricular dyssynchrony in chagas cardiomyopathy [ J ]. Arq Bras Cardiol, 2011,96 (4) : 300-306.
  • 5Wang NC,Bhattacharya S,Gheorghiade M.The potential role of cardiac resynchronization therapy in acute heart failure syndromes [J]. Heart Fail Rev, 2011,16(5) :481-490.
  • 6Sharon AH,William TA,Marshall H, et al.Cardiology/American heart association task force on practice guidelines heart failure in the adult :a report of the American college of ACC/AHA 2005 guideline update for the diagnosis and management of chronic [ J ].Circulation, 2005,112(12) : e154-235.
  • 7Bleeker GB,Schalij MJ,Molhoek SG,et al.Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure [ J ] .J Cardiovasc Electrophysiol, 2004, 15 (5) : 544-549.
  • 8Shamim W, Francis DP, Yousufuddin M, et al.Intraventricular conduction delay: a prognostic marker in chronic heart failure [J ]. Int J Cardiol, 1999,70(2) : 171-178.
  • 9Fosbol EL, Seibaek M, Brendorp B, et al.Prognostic importance of change in QRS duration over time associated with left ventricular dysfunction in patients with congestive heart failure : the DIAMOND study[J]. J Card Fail, 2008,14(10) :850-855.
  • 10Shenkman HJ, Pampati V, Khandelwal AK, et al.Congestive heart failure and QRS duration: establishing prognosis study [J]. Chest, 2002,122 (2) :528-534.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部